Cited by 127Artificial Intelligence in Healthcare and EducationElectronic Health Records SystemsMachine Learning in Healthcare

Artificial Intelligence Tool for Optimizing Eligibility Screening for Clinical Trials in a Large Community Cancer Center

Beck, J. Thaddeus, Rammage, Melissa, Jackson, Gretchen P., Preininger, Anita M., Dankwa-Mullan, Irene, Roebuck, M. Christopher, Torres, Adam, Holtzen, Helen +5 more·2020·JCO Clinical Cancer Informatics

Abstract

PURPOSE: Less than 5% of patients with cancer enroll in clinical trials, and 1 in 5 trials are stopped for poor accrual. We evaluated an automated clinical trial matching system that uses natural language processing to extract patient and trial characteristics from unstructured sources and machine learning to match patients to clinical trials. PATIENTS AND METHODS: Medical records from 997 patients with breast cancer were assessed for trial eligibility at Highlands Oncology Group between May and August 2016. System and manual attribute extraction and eligibility determinations were compared using the percentage of agreement for 239 patients and 4 trials. Sensitivity and specificity of system-generated eligibility determinations were measured, and the time required for manual review and system-assisted eligibility determinations were compared. RESULTS: Agreement between system and manual attribute extraction ranged from 64.3% to 94.0%. Agreement between system and manual eligibility determinations was 81%-96%. System eligibility determinations demonstrated specificities between 76% and 99%, with sensitivities between 91% and 95% for 3 trials and 46.7% for the 4th. Manual eligibility screening of 90 patients for 3 trials took 110 minutes; system-assisted eligibility determinations of the same patients for the same trials required 24 minutes. CONCLUSION: In this study, the clinical trial matching system displayed a promising performance in screening patients with breast cancer for trial eligibility. System-assisted trial eligibility determinations were substantially faster than manual review, and the system reliably excluded ineligible patients for all trials and identified eligible patients for most trials.

Integrity signals

Registry

Crossref · 10.1200/cci.19.00079

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Beck, J. T., Rammage, M., Jackson, G. P., Preininger, A. M., Dankwa-Mullan, I., Roebuck, M. C., Torres, A., Holtzen, H., Coverdill, S. E., Williamson, M. P., Chau, Q., Rhee, K., & Vinegra, M.
Affiliations
  • Highlands Oncology Group (US)
  • IBM (United States) (US)
  • IBM Watson Health, IBM Corporation, Cambridge, MA
  • RxEconomics, Hunt Valley, MD
  • Novartis (United States) (US)
Venue
JCO Clinical Cancer Informatics
Published
2020-11
Volume
4
Issue
4
Pages
50-59
ISSN
2473-4276 (ISSN-L)
OpenAlex
W3001688612
Cited by
127
References
19
Citations by year
2026: 17 · 2025: 28 · 2024: 33 · 2023: 20 · 2022: 7 · 2021: 16 · 2020: 5
FWCI
3.58
Type
journal article
Language
en
Open access
closed
Locations
  • JCO Clinical Cancer Informatics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
  • Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
Keywords
clinical trial eligibility screening, natural language processing, machine learning, breast cancer, cancer clinical trials, trial accrual, attribute extraction
MeSH terms
Machine Learning, Adult, Aged, Aged, 80 and over, Artificial Intelligence, Breast Neoplasms, Clinical Trials as Topic, Eligibility Determination, Female, Humans, Middle Aged, Natural Language Processing, Patient Selection, Community Networks, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review